Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MRPL35P2 (Mitochondrial ribosomal protein L35 pseudogene 2) is a processed pseudogene found in the human genome, originating from the MRPL35 gene, which encodes a protein that forms part of the large subunit of the mitochondrial ribosome[3][6]. Like other processed pseudogenes, MRPL35P2 does not code for a functional protein and has no known biological function, disease association, drug interaction, or role as a biomarker[3][6][8]. It is essentially a “genetic fossil” representing the evolutionary history of its parent gene and is not considered a valid therapeutic target. Key details supporting this assessment: - It is listed in genomic databases (such as GeneCards) specifically as a pseudogene, not as a functional gene or protein[3][6]. - Pseudogenes are generally non-functional and do not encode active proteins[8]. - No biological function, drug interaction, or disease association is indicated in reference databases or the scientific literature[3][6][8]. Summary: MRPL35P2 is a mitochondrially-derived ribosomal pseudogene with no therapeutic or functional relevance, thus it is not a true molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L35 pseudogene 2 (MRPL35P2).